pleiotropy

DEFINITION: One gene → multiple phenotypic effects. Distinct from genetic heterogeneity (many genes/mutations → same phenotype), variable expressivity (same genotype → different severity), and incomplete penetrance (genotype present but no phenotype).

MECHANISM: A gene product may be used in multiple tissues, participate in several pathways, or serve as a structural/signaling component with widespread roles. A single defective protein therefore disrupts many organ systems.

HIGH-YIELD EXAMPLES: - Marfan syndrome (FBN1, fibrillin-1): skeletal (arachnodactyly, tall stature, pectus), ocular (ectopia lentis, upward lens dislocation), cardiovascular (aortic root dilation/dissection, MVP). Reduced fibrillin also increases TGF-β signaling. - Phenylketonuria (PAH): intellectual disability, hypopigmentation (fair skin/light hair/blue eyes, from decreased tyrosine → melanin), eczema, musty body odor. - Sickle cell disease (HBB, Glu6Val): hemolytic anemia, vaso-occlusive pain crises, autosplenectomy and infection risk with encapsulated organisms, stroke, acute chest syndrome, renal papillary necrosis, osteomyelitis (Salmonella). - Cystic fibrosis (CFTR): lung disease, pancreatic insufficiency, meconium ileus, male infertility (absent vas deferens), elevated sweat chloride. - Neurofibromatosis type 1 (NF1): café-au-lait spots, neurofibromas, Lisch nodules, optic glioma, pheochromocytoma (also shows variable expressivity). - Tuberous sclerosis (TSC1/TSC2): hamartomas in brain, skin (ash-leaf spots, angiofibromas), heart (rhabdomyomas), kidney (angiomyolipomas). - Osteogenesis imperfecta (COL1A1/COL1A2): fractures, blue sclerae, hearing loss, dentinogenesis imperfecta. - Ehlers-Danlos, Holt-Oram, Li-Fraumeni, and many other syndromes also illustrate pleiotropy.

CLINICAL SIGNIFICANCE: Explains multisystem syndromes from single-gene defects; guides screening of multiple organ systems once a diagnosis is made (e.g., echocardiography and ophthalmology exams in Marfan). Treating one manifestation does not address the others.

BOARD TIP: Look for stems describing a single inherited disorder with unrelated findings across multiple organ systems → "pleiotropy." Don't confuse with: locus heterogeneity (e.g., retinitis pigmentosa, many loci), allelic heterogeneity (e.g., many CFTR or β-thalassemia mutations), variable expressivity (NF1 severity differing within a family), and incomplete penetrance (BRCA1, retinoblastoma ~90%).